2-[¹⁸F]-fluoro-2-deoxy-D-glucose positron-emission tomography is cost-effective in the initial staging of non-small cell lung cancer patients in Brazil

A tomografia por emissão de pósitrons com 2-[¹⁸F]-fluoro2-desoxi-D-glicose é custo-efetiva em pacientes com câncer de pulmão não pequenas células no Brasil

Juliano Julio Cerci¹; Teresa Yae Takagaki²; Evelinda Trindade³; Roberta Morgado⁴; Fausto Morabito⁵; Rafael Silva Musolino⁵; José Soares Junior⁶; José Cláudio Meneghetti⁷

• Article
• About the authors
• Statistics
• Related content

This work is licensed under an Attribution 4.0 International License (CC BY 4.0), effective June 9, 2022. Previously, the journal was licensed under a Creative Commons Attribution - Non-Commercial - Share Alike 4.0 International License.